JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

Recruiting

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

China

The First Affiliated Hospital of Zhengzhou University, Zhenzhou, Henan